Pharmacokinetics of BIBR277 (Telmisartan) in hypertensive patients with renal insuffisiency

Japanese Pharmacology and Therapeutics

Volumn 30, Issue SUPPL. 1, 2002, Pages

  Ogihara, Toshio ^a   Sakai, Rumi ^a   Fujita, Yoshikazu ^a   Shinkou, Satoko ^a   Azekura, Hisanori ^a   Obayashi, Takaaki ^a   Tsuruta, Yoshinari ^a   Tatami, Shinji ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TELMISARTAN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELIMINATION; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MALE; SYSTOLIC BLOOD PRESSURE;

EID: 0036031286     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hannedouche T, et al. Evaluation of the safety and efficacy of Telmisartan and Enalapril, with the potential addition of Furosemide, in moderate-renal failure patients with mild-to-moderate hypertension. J Renin Angiotensin Aldosterone Syst 2001; 2: 246-54.
2. Stangier J, et al. Pharmacokinetics of single-dose Telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: Comparison with healthy volunteers. J Clin Pharmacol 2000; 40: 1365-1372.